In yesterday’s Wall Street session, Accolade Inc (NASDAQ:ACCD) shares traded at $7.97, up 1.14% from the previous session.
15 analysts cover Accolade Inc (NASDAQ:ACCD), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $17.00 and a low of $10.00, we find $16.00. Given the previous closing price of $7.88, this indicates a potential upside of 103.05 percent. ACCD stock price is now -6.44% away from the 50-day moving average and -32.92% away from the 200-day moving average. The market capitalization of the company currently stands at $607.55M.
The stock has received a hold rating from 4 analysts and a buy rating from 10. Brokers who have rated the stock have averaged $14.54 as their price target over the next twelve months.
With the price target maintained at $16.50, BofA Securities recently Upgraded its rating from Neutral to Buy for Accolade Inc (NASDAQ: ACCD).
In other news, SINGH RAJEEV, Chief Executive Officer sold 358 shares of the company’s stock on Nov 17. The stock was sold for $2,843 at an average price of $7.94. Upon completion of the transaction, the Chief Executive Officer now directly owns 739,742 shares in the company, valued at $5.9 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 17, President Cavanaugh Robert N sold 149 shares of the business’s stock. A total of $1,183 was realized by selling the stock at an average price of $7.94. This leaves the insider owning 168,086 shares of the company worth $1.34 million. Insiders disposed of 37,501 shares of company stock worth roughly $0.3 million over the past 1 year. A total of 10.06% of the company’s stock is owned by insiders.
On Wednesday morning Accolade Inc (NASDAQ: ACCD) stock kicked off with the opening price of $8.02. During the past 12 months, Accolade Inc has had a low of $6.33 and a high of $17.00. As of last week, the company has a debt-to-equity ratio of 0.72, a current ratio of 3.04, and a quick ratio of 3.04. The fifty day moving average price for ACCD is $8.52 and a two-hundred day moving average price translates $11.88 for the stock.
The latest earnings results from Accolade Inc (NASDAQ: ACCD) was released for Aug, 2023. According to the Health Information Services Company, earnings per share came in at -$0.43, beating analysts’ expectations of -$0.54 by 0.11. This compares to -$0.66 EPS in the same period last year. The net profit margin was -37.24% and return on equity was -29.99% for ACCD. The company reported revenue of $96.86 million for the quarter, compared to $87.64 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 10.52 percent. For the current quarter, analysts expect ACCD to generate $96.22M in revenue.
Accolade Inc(ACCD) Company Profile
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. It also provides medical opinion and decision support services; and technology and administrative services to the medical practice PCs providing virtual primary care services. The company serves employers who provide their employees and their employees’ families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.
